APA (7th ed.) Citation

Nguyen, A., Fullard, K., Sheehan‐Dare, G., Tang, R., Chan, L., Ho, B., . . . Emmett, L. (2022). Diagnostic value of 68Ga‐DOTATATE PET‐CT imaging for staging of ER+/PR+ HER2‐ breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and 18F‐FDG PET‐CT in a prospective pilot trial. Journal of Medical Imaging & Radiation Oncology, 66(6), 731. https://doi.org/10.1111/1754-9485.13342

Chicago Style (17th ed.) Citation

Nguyen, Andrew, et al. "Diagnostic Value of 68Ga‐DOTATATE PET‐CT Imaging for Staging of ER+/PR+ HER2‐ Breast Cancer Patients with Metastatic Disease: Comparison with Conventional Imaging with Bone Scan, Diagnostic CT and 18F‐FDG PET‐CT in a Prospective Pilot Trial." Journal of Medical Imaging & Radiation Oncology 66, no. 6 (2022): 731. https://doi.org/10.1111/1754-9485.13342.

MLA (9th ed.) Citation

Nguyen, Andrew, et al. "Diagnostic Value of 68Ga‐DOTATATE PET‐CT Imaging for Staging of ER+/PR+ HER2‐ Breast Cancer Patients with Metastatic Disease: Comparison with Conventional Imaging with Bone Scan, Diagnostic CT and 18F‐FDG PET‐CT in a Prospective Pilot Trial." Journal of Medical Imaging & Radiation Oncology, vol. 66, no. 6, 2022, p. 731, https://doi.org/10.1111/1754-9485.13342.